The use of antibodies in clinical cardiology.
Monoclonal antibody technology has resulted in an entirely new class of agents, which have been applied to a variety of problems in cardiology and which hold great promise for future diagnostic, as well as therapeutic, applications. The four antibodies, which have been most widely used in clinical cardiology, are Digibind, OKT3, Myoscint, and 7E3. Each demonstrates the unique potential for the use of antibodies in clinical cardiology.
Azrin
M A
MA
Yale University School of Medicine, Division of Cardiovascular Medicine, New Haven, CT 06510.
D000906:Antibodies / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000096:biosynthesis / Q000627:therapeutic use; D001792:Blood Platelets / Q000276:immunology / Q000502:physiology; D004077:Digoxin / Q000276:immunology; D006084:Graft Rejection; D006331:Heart Diseases / Q000175:diagnosis* / Q000628:therapy; D016027:Heart Transplantation; D006801:Humans; D016853:Muromonab-CD3 / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000000981:diagnostic imaging; D009205:Myocarditis / Q000000981:diagnostic imaging; D009218:Myosins / Q000276:immunology; D011877:Radionuclide Imaging; D011948:Receptors, Antigen, T-Cell / Q000276:immunology
D000906:Antibodies; D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3; D011948:Receptors, Antigen, T-Cell; D004077:Digoxin; D009218:Myosins